# Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade

> **NCT05037006** · PHASE4 · UNKNOWN · sponsor: **Pontificia Universidade Catolica de Sao Paulo** · enrollment: 90 (estimated)

## Conditions studied

- Neuromuscular Blockade
- Neuromuscular Blockade, Residual

## Interventions

- **DRUG:** Sevoflurane - Neostigmine 30
- **DRUG:** Sevoflurane - Neostigmine 50
- **DRUG:** Sevoflurane - Neostigmine 70
- **DRUG:** TIVA - Neostigmine 30
- **DRUG:** TIVA - Neostigmine 50
- **DRUG:** TIVA - Neostigmine 70

## Key facts

- **NCT ID:** NCT05037006
- **Lead sponsor:** Pontificia Universidade Catolica de Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2021-12-20
- **Final completion:** 2021-12-20
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2021-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05037006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05037006, "Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05037006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*